Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Suzawa; Toshiyuki
Address:
Yamato, JP
No. of patents:
9
Patents:












Patent Number Title Of Patent Date Issued
7547675 Chemically modified polypeptides June 16, 2009
The present invention relates to a chemically modified polypeptide in which at least one of hydroxyl groups in the polypeptide molecule is modified with a polyalkylene glycol derivative; a method for producing the modified polypeptide; a method of treatment using the modified polypep
7291713 Branched polyalkylene glycols November 6, 2007
The present invention provides a branched polyalkylene glycol wherein three or more single-chain polyalkylene glycols and a group having reactivity with an amino acid side chain, the N-terminal amino group or the C-terminal carboxyl group in a polypeptide or a group convertible into
6642355 Endothelin-antagonizing peptide November 4, 2003
The invention relates to an endothelin antagonistic peptide of the formula (I):wherein represents Asn or Asp; B represents His or Lys; E represents Ala or Ser; G represents Ala or Pro; X represents X.sup.1 -Gly or ##STR1## and Y represents hydroxy, lower alkoxy, amino, #
6638509 Toxin conjugates October 28, 2003
The present invention relates to a toxin conjugate in which a residue derived from a compound having an affinity for a target cell is bound to a toxin through a spacer comprising polyalkylene glycol and dipeptide.
6583267 Chemically modified polypeptides June 24, 2003
The present invention relates to a chemically modified polypeptide in which at least one of hydroxyl groups in the polypeptide molecule is modified with a polyalkylene glycol derivative; a method for producing the modified polypeptide; a method of treatment using the modified polypeptide
6194195 Strains of streptomyces producing endothelin antagonistic peptides February 27, 2001
The invention relates to biologically pure cultures of Streptomyces sp. RE-701 (FERM BP-3624) and Streptomyces sp. RE-629 (FERM BP-4126) that produce endothelin antagonistic peptides.
6103236 Toxin conjugates August 15, 2000
The present invention relates to a toxin conjugate in which a residue derived from a compound having an affinity for a target cell is bound to a toxin through a spacer comprising polyalkylene glycol and dipeptide.
5639860 Endothelin-antagonizing peptide June 17, 1997
Peptides represented by the following formula (I): ##STR1## wherein A represents Asn or Asp; B represents His or Lys; and E represents Ala or Ser;(1) X.sup.1 and Y.sup.1 are combined together to form a single bond as X.sup.1 --Y1, or (2) X.sup.1 represents hydrogen and Y.sup.1 repres
5631222 Endothelin-antagonizing peptide May 20, 1997
Disclosed is a peptide compound represented by the following formula (I):wherein R.sup.1-12, R.sup.14-18, and R.sup.20 are as defined in the specification.










 
 
  Recently Added Patents
System and method for providing dynamic navigation through a property to a selected destination
Electronic device, display, image processing apparatus and electronic calculating apparatus
Transaction finance processing system and approach
Organic light-emitting display and method of manufacturing the same
Light fixture
Method for computing an energy efficient route
PVD coated tool
  Randomly Featured Patents
Mounting bracket for electro-optic devices for firearms and other equipment
Vehicle power distributor and method of producing the same
Silsesquioxane resin with high strength and fracture toughness and method for the preparation thereof
Zoom lens of high power varying ratio
Sink divider top
Solar oxy-hydrogen vehicle
Aromatized food package
Chromium carbide sintered body
Press with movable workpiece support carrier
Coating thickness measurement gauge